May ended with procurement becoming the primary regulator for clinical AI, imaging and primary care tech as Healthdirect Australia, ADHA and the My Health Record upgrade rewired what buyers will buy. MEDITECH’s ambient note capture, Telstra Health’s Corus iX, Lunit’s BreastScreen win and the new bulk‑billing consent rule forced vendors to show identity, audit and onshore data handling or lose access to big public and private deals.

Governance gates

Healthdirect’s clinician‑led procurement rules and ADHA’s National Framework made clinician accountability, continuous safety surveillance and auditable logs contract essentials. MEDITECH’s live scribe features amplified demands for identity, access and immutable records. Who wins: large EMR vendors, well capitalised integrators and vendors that can demonstrate explainability and monitoring pipelines. Who loses: small app builders and owner operators who lack post‑launch surveillance or standardised APIs. The forced decision is binary for many suppliers: build monitoring, embed consent capture and identity controls, or be excluded from state and federal tenders.

Interoperability premium

Telstra Health positioning Corus iX as a FHIR native care spine, ADHA saying the interoperability plan is largely complete and Lunit’s onshore win shifted procurement toward where data is stored and how it flows. Platforms that join referral through billing, or prove live FHIR endpoints, now capture margin that point solutions cannot. Overseas models without Australian processing and clear legal agreements are under direct pressure. Procurement evaluators will demand live exchange tests, not paper attestations, so technical conformance is a market filter.

Capital and execution

ANDHealth’s survey and tax policy moves tightened the clock on founders. With 92 per cent of SMEs seeking growth capital and deals like Jardines’ AUD 3.4 billion I‑MED purchase, scale is trading at a premium. That pushes startups toward export evidence or M&A. Execution risk rose in parallel. Epic’s Hunter New England go‑live and the Manage My Health breach raised the cost of delivery and vendor risk transfer. Buyers will pay for demonstrable security and implementation support, shifting advantage to vendors that can fund or underwrite deployments.

Caution or constraint

Mandates assume capacity that the system does not uniformly have. Single points of failure in government APIs, persistent digital literacy gaps among older Australians and strained clinical workforces limit how fast benefits convert into outcomes. Boards must require live interoperability tests, SLAs for identity and incident recovery, and funded integration support for small practices if the procurement rules are to deliver the promised gains.